May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
The role of proteinases in the alteration of blood retinal barrier permeability
Author Affiliations & Notes
  • S.J. Giebel
    Cell Biology/Physiology,
    Univ New Mexico, Albuquerque, NM
  • J. Jaramillo
    Cell Biology/Physiology,
    Univ New Mexico, Albuquerque, NM
  • S. Colombo
    Cell Biology/Physiology,
    Univ New Mexico, Albuquerque, NM
  • A. Das
    Surgery,
    Univ New Mexico, Albuquerque, NM
  • P. McGuire
    Cell Biology/Physiology,
    Univ New Mexico, Albuquerque, NM
  • Footnotes
    Commercial Relationships  S.J. Giebel, None; J. Jaramillo, None; S. Colombo, None; A. Das, None; P. McGuire, None.
  • Footnotes
    Support  NIH RO1 EY12604–05 (A.D.)
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 449. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.J. Giebel, J. Jaramillo, S. Colombo, A. Das, P. McGuire; The role of proteinases in the alteration of blood retinal barrier permeability . Invest. Ophthalmol. Vis. Sci. 2004;45(13):449.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The blood–retinal barrier (BRB) is maintained by tight junctions between either capillary endothelial cells or the retinal pigment epithelium (RPE). The breakdown of tight junction proteins may result in altered retinal permeability. The aim of this study is to determine the role of proteinases in the alteration of the BRB through the proteolysis of the tight junction protein occludin. Methods: Transepithelial electrical resistance (TEER) was performed to quantify tight junction integrity and cellular permeability on confluent human retinal pigmented epithelial cells (ARPE–19) or endothelial cells (HUVEC). Cells were treated with PMA or purified MMP–9, with or without an MMP inhibitor. Western blot analysis for the protein occludin was performed. Results: RPE cells treated with PMA demonstrated a significant decrease in TEER. Treating RPE cells with purified MMP–9 demonstrated a dose dependent decrease in resistance. These effects were partially prevented by co–treatment with an MMP inhibitor. Western blot analysis revealed alterations in the occludin protein from RPE cells treated with MMP–9, which could be prevented by treatment with an MMP inhibitor. Conclusions: Increased expression of proteinases may play a role in the alteration of the BRB through their action on the tight junction protein occludin, and may be important in the pathophysiology of altered BRB permeability.

Keywords: proteolysis • retina • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×